Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7423660
Reference Type
Journal Article
Title
Acute cholinergic syndrome in a patient with mild Alzheimer's type dementia who had applied a large number of rivastigmine transdermal patches on her body
Author(s)
Suzuki, Y; Kamijo, Y; Yoshizawa, T; Fujita, Y; Usui, K; Kishino, T; ,
Year
2017
Is Peer Reviewed?
1
Journal
Clinical Toxicology
ISSN:
1556-3650
EISSN:
1556-9519
Publisher
TAYLOR & FRANCIS LTD
Location
ABINGDON
Volume
55
Issue
9
Page Numbers
1008-1010
Language
English
PMID
28594244
DOI
10.1080/15563650.2017.1329536
Web of Science Id
WOS:000410940900012
URL
https://www.tandfonline.com/doi/full/10.1080/15563650.2017.1329536
Exit
Abstract
A 91-year-old woman was transferred to our Emergency Medical Center and Poison Center with somnolence, hypertension (186/61 mm Hg), and repeated vomiting. Three hours later, 10 transdermal patches, each containing 18 mg of rivastigmine (9.5 mg/24 h), were found on her lower back and both thighs, when miosis, facial and trunk sweating, enhanced bowel sound, hypertension, and sinus tachycardia were noted. She was diagnosed with acute cholinergic syndrome due to rivastigmine poisoning. Her hypertension and sinus tachycardia peaked 8 and 5 h after all the patches were removed, respectively. Her symptoms subsided spontaneously after 17 h.
Keywords
acute cholinergic syndrome; Alzheimerâs type dementia; butyrylcholinesterase; Rivastigmine; transdermal patch; alpha amylase pancreas isoenzyme; cholinesterase; ketoprofen; prescription drug; rivastigmine; cholinesterase inhibitor; rivastigmine; aged; Alzheimer disease; anticholinergic syndrome; Article; back; blood pressure; body temperature; brain atrophy; breathing rate; case report; clinical article; computer assisted tomography; device removal; drug blood level; elimination half-life; enzyme activity; enzyme blood level; face; female; heart rate; hospital admission; human; hypertension; inguinal pain; intestine sound; leukocytosis; low back pain; miosis; neuroimaging; prescription; sinus rhythm; sinus tachycardia; somnolence; sweating; thigh; toxicity testing; transdermal patch; trunk; very elderly; vomiting; Alzheimer disease; chemically induced; cutaneous drug administration; drug effects; drug overdose; hypertension; Neurotoxicity Syndromes; pathophysiology; psychology; severity of illness index; Tachycardia, Sinus; transdermal patch; Administration, Cutaneous; Aged, 80 and over; Alzheimer Disease; Blood Pressure; Cholinesterase Inhibitors; Drug Overdose; Female; Heart Rate; Humans; Hypertension; Neurotoxicity Syndromes; Rivastigmine; Severity of Illness Index; Tachycardia, Sinus; Transdermal Patch
Tags
Other
•
Harmful Algal Blooms- Health Effects
April 2021 Literature Search
PubMed
WOS
Scopus
Saxitoxins
PubMed
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity